Medication
Lacosamide
DIN 02512874 · Sanis Health Inc Likely a generic
What it is
- Active ingredients
- Lacosamide — 50 mg
- Form and route
- Tablet · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2021-09-27
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Vimpat
- Teva-Lacosamide
- Sandoz Lacosamide
- Auro-Lacosamide
- Pharma-Lacosamide
- ZDS-Lacosamide
- Jamp-Lacosamide
- Ach-Lacosamide
- Mint-Lacosamide
- Riva-Lacosamide
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
Watch this medication
Ontario Drug Benefit coverage
As of 31 July 2026Limited Use benefit Part XII
Ontario lists this product as a Limited Use benefit — Part XII of the Formulary/CDI. ODB pays for it only in the specific circumstances Ontario sets out against it, and the prescription has to carry a Limited Use code from the prescriber.
The criteria are set by Ontario and are not reproduced here — they are a matter for the prescriber.
- What ODB pays per unit
- $0.6313
This is what the Ontario Drug Benefit program reimburses a pharmacy for one unit, as of 31 July 2026. A deductible and a co-payment sit on top of it and differ by program — ODB, the Trillium Drug Program and the seniors co-payment each work differently — so it is not the figure anyone is charged at a counter. It also says nothing about private, workplace or federal coverage.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
Products Ontario considers interchangeable
As of 31 July 2026Ontario groups these products together at 50mg Tab and will substitute one for another at a pharmacy counter in Ontario.
- Ach-Lacosamide 02489287Accord Healthcare Inc
- Auro-Lacosamide 02475332Auro Pharma Inc
- Jamp-Lacosamide 02488388Jamp Pharma Corporation
- Mint-Lacosamide 02490544Mint Pharmaceuticals Inc
- Pharma-Lacosamide 02478196Pharmascience Inc
- Sandoz Lacosamide 02474670Sandoz Canada Incorporated
- Teva-Lacosamide 02472902Teva Canada Limited
- Vimpat 02357615Ucb Canada Inc
- ZDS-Lacosamide 02487802Zydus Pharmaceuticals (Canada) Inc
Ontario lists 1 further product in this group that is not currently marketed in Canada. It is not shown.
This is Ontario’s designation, under the Ontario Drug Benefit program, and it applies in Ontario. It is a different statement from the same-active-ingredient list above, which is Health Canada’s grouping and carries no substitution meaning at all. No other province’s rules are shown on this page, and a designation here is not a recommendation to switch — that is a conversation with a pharmacist or prescriber.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Nervous system
- ATC code
- N03AX18
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of N03AX18, see the WHO ATC/DDD Index.
Recalls and safety alerts
As of 12 August 2026Health Canada has published a recall or safety alert naming this product. Read it on Health Canada’s own site, and speak to a pharmacist before changing anything about how you take this medication.
Lacosamide 10mg/ml : Presence of particulate matter in affected lot.
Health Canada says: Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Matched on the product name at the start of the notice.
This list may be incomplete. Health Canada’s recalls data carries no DIN, so notices are matched on wording alone. Search Health Canada recalls for Lacosamide → How RxMonitor matches recalls, and how often it fails
Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.